Community/Retail

Currently, the plan is to role out Viagra Connect in the first or second quarter of 2018.

The FDA is monitoring reports of adverse events associated with biotin interference with laboratory tests and will update the public if significant new information becomes available.

As the most accessible health care providers, pharmacists may be asked questions regarding physical activity from patients with arthritis, and it’s important to advise them to keep moving.

It’s been more than 6 decades since Professor R. Keith Campbell, from Washington State University, was diagnosed with diabetes.

The illness is prevalent in the eastern United States. Diagnosis can be challenging, and the progression can lead to harmful complications.

We have all heard of self-sabotage, but what about self-handicapping?

This month marks the 45th anniversary of the introduction of the pharmacy stamp. A collector of the commemorative envelopes of first-day covers ruminates on his hobby.

The FDA is investigating the medical food product for serious adverse effects. A pharmacist can convey this information to patients.

Over the years, a number of landmark clinical trials in the field of hypertension have been published, shaping how the disease is treated.

While Proteus and Otsuka's recently-FDA approved smart pill is making big news, there are other start-ups making some strides into the market.

Many of us picture ourselves drowning in a frenzy of wrapping paper, eggnog, and in-laws. But help is on the way.

One glaring omission is the lack of psychiatric medications included.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Those who are looking to do more than just clock in and go through the motions will find exceptional value in these principles.

Here is a cheat sheet on information related to infants and older kids.

The FDA recommends the device not to be used in patients taking systemic medication that could increase sensitivity to UV light.

The National Kidney Foundation’s Dietary Guidelines for adults starting on hemodialysis instructs patients to avoid this tropical treat. Why?

Believe it or not, the road from student to licensed professional is similar to Harry Potter's hero journey.

Officials with the FDA have released a guidance on the development of generic abuse-deterrent opioids. The final guidance is part of the agency’s effort to reduce abuse by decreasing unnecessary exposure to opioids.

Juluca is indicated as a complete therapy for patients with HIV-1.

The Pharmacy Times Continuing Education (PTCE) team recently submitted photos of themselves doing various activities, including running and painting, in support of the #APharmacistIs campaign.

The retail pharmacy and health care company will bring prescriptions to patients' doors in select cities, but this raises several questions.

What do pharmacists need to know about these mobile applications recently approved by the FDA?

Officials with the FDA have expanded the approval of Kaleo’s epinephrine injection, USP (Auvi-Q) to include the treatment of life-threatening allergic reactions in infants and small children.

November is diabetes awareness month, and pharmacists are excellent resources for patients who have this chronic condition.

The recent outbreak in Disneyland sheds light on common sources of infection and prevention strategies.

William Schaffner, MD, medical director for the National Foundation for Infectious Diseases’ (NFID) and infectious disease physician at Vanderbilt, explains how health care providers can work towards getting patients who are aged 65 and older to receive an influenza vaccine.

Does this represent an opportunity for pharmacists to use such devices to help monitor adherence in patients?